These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12539045)

  • 1. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors.
    Chen WY; Zeng X; Carter MG; Morrell CN; Chiu Yen RW; Esteller M; Watkins DN; Herman JG; Mankowski JL; Baylin SB
    Nat Genet; 2003 Feb; 33(2):197-202. PubMed ID: 12539045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chromosome arm 17p13.3: could HIC1 be the one ?].
    Chopin V; Leprince D
    Med Sci (Paris); 2006 Jan; 22(1):54-61. PubMed ID: 16386221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis.
    Chen W; Cooper TK; Zahnow CA; Overholtzer M; Zhao Z; Ladanyi M; Karp JE; Gokgoz N; Wunder JS; Andrulis IL; Levine AJ; Mankowski JL; Baylin SB
    Cancer Cell; 2004 Oct; 6(4):387-98. PubMed ID: 15488761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1.
    Britschgi C; Rizzi M; Grob TJ; Tschan MP; Hügli B; Reddy VA; Andres AC; Torbett BE; Tobler A; Fey MF
    Oncogene; 2006 Mar; 25(14):2030-9. PubMed ID: 16301995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a second G-C-rich promoter conserved in the human, murine and rat tumor suppressor genes HIC1.
    Pinte S; Guérardel C; Deltour-Balerdi S; Godwin AK; Leprince D
    Oncogene; 2004 May; 23(22):4023-31. PubMed ID: 15007385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation of the HIC1 promoter is a frequent event in specific pediatric neoplasms.
    Rathi A; Virmani AK; Harada K; Timmons CF; Miyajima K; Hay RJ; Mastrangelo D; Maitra A; Tomlinson GE; Gazdar AF
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3674-8. PubMed ID: 14506157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A L225A substitution in the human tumour suppressor HIC1 abolishes its interaction with the corepressor CtBP.
    Stankovic-Valentin N; Verger A; Deltour-Balerdi S; Quinlan KG; Crossley M; Leprince D
    FEBS J; 2006 Jul; 273(13):2879-90. PubMed ID: 16762039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
    Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
    Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.
    Chen WY; Wang DH; Yen RC; Luo J; Gu W; Baylin SB
    Cell; 2005 Nov; 123(3):437-48. PubMed ID: 16269335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of HRG22, a human homologue of the putative tumor suppressor gene HIC1.
    Deltour S; Pinte S; Guérardel C; Leprince D
    Biochem Biophys Res Commun; 2001 Sep; 287(2):427-34. PubMed ID: 11554746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIC1 attenuates Wnt signaling by recruitment of TCF-4 and beta-catenin to the nuclear bodies.
    Valenta T; Lukas J; Doubravska L; Fafilek B; Korinek V
    EMBO J; 2006 Jun; 25(11):2326-37. PubMed ID: 16724116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implication of HIC1 (Hypermethylated In Cancer 1) in the DNA damage response.
    Dehennaut V; Leprince D
    Bull Cancer; 2009 Nov; 96(11):E66-72. PubMed ID: 19822477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted disruption of the 3p12 gene, Dutt1/Robo1, predisposes mice to lung adenocarcinomas and lymphomas with methylation of the gene promoter.
    Xian J; Aitchison A; Bobrow L; Corbett G; Pannell R; Rabbitts T; Rabbitts P
    Cancer Res; 2004 Sep; 64(18):6432-7. PubMed ID: 15374951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of two modified mouse alleles of the Hic1 tumor suppressor gene.
    Pospichalova V; Tureckova J; Fafilek B; Vojtechova M; Krausova M; Lukas J; Sloncova E; Takacova S; Divoky V; Leprince D; Plachy J; Korinek V
    Genesis; 2011 Mar; 49(3):142-51. PubMed ID: 21309068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIC1 promoter methylation and 17p13.3 allelic loss in invasive ductal carcinoma of the breast.
    Parrella P; Scintu M; Prencipe M; Poeta ML; Gallo AP; Rabitti C; Rinaldi M; Tommasi S; Paradiso A; Schittulli F; Valori VM; Toma S; Altomare V; Fazio VM
    Cancer Lett; 2005 May; 222(1):75-81. PubMed ID: 15837543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIC1 hypermethylation is a late event in hematopoietic neoplasms.
    Issa JP; Zehnbauer BA; Kaufmann SH; Biel MA; Baylin SB
    Cancer Res; 1997 May; 57(9):1678-81. PubMed ID: 9135007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma.
    Stöcklein H; Smardova J; Macak J; Katzenberger T; Höller S; Wessendorf S; Hutter G; Dreyling M; Haralambieva E; Mäder U; Müller-Hermelink HK; Rosenwald A; Ott G; Kalla J
    Oncogene; 2008 Apr; 27(18):2613-25. PubMed ID: 17982487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia.
    Yu L; Liu C; Vandeusen J; Becknell B; Dai Z; Wu YZ; Raval A; Liu TH; Ding W; Mao C; Liu S; Smith LT; Lee S; Rassenti L; Marcucci G; Byrd J; Caligiuri MA; Plass C
    Nat Genet; 2005 Mar; 37(3):265-74. PubMed ID: 15723065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and developmental expression of the zebrafish orthologue of the tumor suppressor gene HIC1.
    Bertrand S; Pinte S; Stankovic-Valentin N; Deltour-Balerdi S; Guérardel C; Bégue A; Laudet V; Leprince D
    Biochim Biophys Acta; 2004 Apr; 1678(1):57-66. PubMed ID: 15093138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation profile of kidney cancer.
    Dulaimi E; Ibanez de Caceres I; Uzzo RG; Al-Saleem T; Greenberg RE; Polascik TJ; Babb JS; Grizzle WE; Cairns P
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3972-9. PubMed ID: 15217927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.